Novo Nordisk A/S: Diabetes Mellitus, Type 2 trials

The registry lists 633 Diabetes Mellitus, Type 2 studies with Novo Nordisk A/S as lead sponsor. 22 are open to participants now and 175 have results posted.

Phase 1 122Phase 2 37Phase 3 184Phase 4 75No phase 215(a study in two phases counts in both)

Studies

Page 3 of 7. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With CagrilintideActive, not recruitingNCT07220759Phase 3
• CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in IndiaCompletedNCT07121114
• A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin PumpCompletedNCT07068295Phase 1
• User Experience With DuraTouch® in Patients With Type 1 or Type 2 DiabetesCompletedNCT07052292
• A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body WeightCompletedNCT07004322Phase 1
• A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyCompletedNCT06797869Phase 2
• SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world DataCompletedNCT06769646
• Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting InsulinCompletedNCT06592950
• A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 DiabetesCompletedNCT06567041Phase 1
• A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedNCT06559527Phase 1
• A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 DiabetesCompletedNCT06542874Phase 2
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothCompletedNCT06534411Phase 3
• Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 DiabetesCompletedNCT06517784
• A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After MenopauseCompletedNCT06513104Phase 1
• Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 DiabetesCompletedNCT06507475
• A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This TreatmentCompletedNCT06478550
• Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 DiabetesCompletedNCT06403761Phase 1
• A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney FunctionCompletedNCT06370819Phase 1
• Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)CompletedNCT06351748
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 DiabetesCompletedNCT06326047Phase 2
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseCompletedNCT06323174Phase 3
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without MetforminCompletedNCT06323161Phase 3
• A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingCompletedNCT06288412Phase 1
• SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in HungaryCompletedNCT06269120
• A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)CompletedNCT06269107Phase 3
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06221969Phase 3
• A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar LevelCompletedNCT06153537
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboCompletedNCT06131372Phase 2
• A Research Study in Italy to Understand How the Dose Check App Used With Xultophy® Works in the Treatment of People Living With Type 2 DiabetesWithdrawnNCT06113341
• Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 DiabetesWithdrawnNCT06083675Phase 3
• A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06065540Phase 3
• A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese MenCompletedNCT05870670Phase 1
• A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and TeenagersCompletedNCT05790681Phase 1
• DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in ItalyCompletedNCT05755360
• Attitudes and Unmet Needs Among Type 2 Diabetes PatientsCompletedNCT05737810
• O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and KuwaitCompletedNCT05716724
• A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) DoseCompletedNCT05689099Phase 1
• A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand.CompletedNCT05542420
• A Research Study of a New Medicine NNC0113-6856 in Healthy MalesCompletedNCT05521256Phase 1
• Phase 2 Study of INV-202 in Patients With Diabetic Kidney DiseaseCompletedNCT05514548Phase 2
• A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in IndiaCompletedNCT05502562
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese MenCompletedNCT05498610Phase 1
• A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in CroatiaWithdrawnNCT05479591
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical PracticeWithdrawnNCT05473286
• A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)CompletedNCT05468632
• Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and ObesityWithdrawnNCT05444153Phase 3
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical PracticeCompletedNCT05443568
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeCompletedNCT05443334
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical PracticeCompletedNCT05443191
• A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCompletedNCT05435677Phase 1
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCompletedNCT05394519Phase 3
• Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in ColombiaCompletedNCT05324462
• An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and AfricaCompletedNCT05317845
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical PracticeCompletedNCT05316662
• A Clinical Trial Looking at the Comparability of 2 Different Forms of SemaglutideCompletedNCT05232708Phase 1
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeCompletedNCT05230615
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical PracticeCompletedNCT05230589
• China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)CompletedNCT05221580
• A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After MenopauseCompletedNCT05153564Phase 1
• A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy PeopleCompletedNCT05046873Phase 1
• A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney FunctionCompletedNCT05015894Phase 1
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedNCT05013229Phase 3
• Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in KoreaCompletedNCT04952779
• Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in LebanonCompletedNCT04892069
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical PracticeCompletedNCT04878393
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical PracticeCompletedNCT04862923
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 DiabetesCompletedNCT04857398Phase 1
• GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.CompletedNCT04838743
• A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide TabletsCompletedNCT04817644Phase 1
• Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different TreatmentsCompletedNCT04809311
• A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 DiabetesCompletedNCT04698018Phase 1
• A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in ItalyCompletedNCT04666987
• A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South KoreaCompletedNCT04656106
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical PracticeCompletedNCT04601753
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical PracticeCompletedNCT04601740
• A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver DiseaseCompletedNCT04597697Phase 1
• A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 DiabetesCompletedNCT04582448Phase 1
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesCompletedNCT04582435Phase 1
• A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin GlargineCompletedNCT04575181Phase 1
• Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry DataCompletedNCT04572165
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical PracticeCompletedNCT04559815
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical PracticeCompletedNCT04537637
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical PracticeCompletedNCT04537624
• Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy PeopleCompletedNCT04524832Phase 1
• Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®CompletedNCT04469855
• A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in RussiaCompletedNCT04315688
• SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 DiabetesWithdrawnNCT04287179Phase 3
• A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 DiabetesCompletedNCT04262661Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)CompletedNCT04261933
• First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With DiabetesCompletedNCT04259801Phase 1
• A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in ChinaCompletedNCT04227431
• A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection PensCompletedNCT04152915Phase 1
• A Study to Look at How Safe NNC0268-0965 is in People With Type 2 DiabetesCompletedNCT04136067Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeCompletedNCT04094415
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)CompletedNCT04083820
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeCompletedNCT04067999
• A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical PracticeCompletedNCT04042441
• A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 DiabetesCompletedNCT04032197Phase 1
• A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are ChineseCompletedNCT04016974Phase 1
• An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical PracticeCompletedNCT03987802